Healthcare & Life Sciences
& Biomanufacturing Debt Capital
Structured Finance arranges senior debt and mezzanine capital facilities for regional healthcare campuses, biopharma R&D wet labs, cGMP biomanufacturing facilities, and specialized medical infrastructure globally.
Financing High-CapEx Medical & Life Science Infrastructure
Financing healthcare campuses, wet labs, and biomanufacturing assets requires underwriting specialized physical infrastructure, tenant improvement allowances, and regulatory compliance. As commercial banks restrict debt on speculative lab space and enforce low leverage caps, direct private credit provides the structured capital necessary to execute critical medical developments.
The Traditional Bank Challenge
-
×
Restrictive Leverage Caps: Banks cap debt at 55% to 65% LTC for healthcare assets and pull back sharply on speculative wet lab developments without heavy pre-leasing.
-
×
Extreme TI Capital Burden: High fit-out costs ($200–$400+/sq ft for wet labs and processing) force sponsors into heavy liquidity reserves under rigid bank loan terms.
-
×
Floating Rate Volatility: Commercial facilities rely on floating SOFR rates, exposing multi-year development, stabilization, and lease-up windows to rate fluctuations.
-
×
Conversion & Compliance Stalls: Banks penalize adaptive reuse projects and enforce rigid compliance covenants before releasing debt draws.
The Structured Finance Solution
-
✓
Higher Leverage: We structure combined senior and mezzanine debt stacks that reach up to 90% LTC, drastically reducing the sponsor's cash equity burden.
-
✓
Fixed-Rate Certainty: All placed facilities utilize fixed interest rates, protecting your underwriting model from market volatility from ground-break to stabilization.
-
✓
Direct Private Capital: We place debt directly with private institutional lenders, eliminating the delays and friction of relying on a dozen regional banks to share the note.
-
✓
Non-Recourse Protection: Placements are underwritten against asset quality and projected yield, allowing for non-recourse debt subject only to standard carve-outs.
Covered Healthcare & Life Science Sectors
cGMP Biomanufacturing & Processing Facilities
Construction and expansion debt for cleanroom processing plants, advanced biomanufacturing hubs, and specialized pharmaceutical production centers.
Biopharma R&D & Wet Lab Complexes
Senior financing for high-spec life science wet labs, biotech incubator hubs, research complexes, and specialized technology parks.
Regional Hospital Wings & Healthcare Campuses
Ground-up construction and debt recapitalizations for acute care hospitals, specialized surgical wings, and regional health network developments.
Specialized Medical Office Buildings (MOBs)
Capital placement for credit-tenant medical office buildings, ambulatory surgical centers (ASCs), and advanced diagnostic imaging facilities.
Life Science Adaptive Reuse & Conversions
Financing for high-capacity office-to-lab structural retrofits, heavy ventilation upgrades, and floor-load reinforcements.
And Other Healthcare & Life Science Infrastructure
Bespoke debt facilities for specialized medical research centers, proton therapy hubs, and healthcare infrastructure assets worldwide.
Submit Your Healthcare Project
If you have a healthcare, life science, or biomanufacturing project requiring debt financing, submit your project details directly to our origination desk for underwriting review.